Home > Financial Ratios > BIOCON

BIOCON
Fixed Capital/Sales

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 2.452.061.311.361.29

What is the latest Fixed Capital/Sales ratio of BIOCON ?

The latest Fixed Capital/Sales ratio of BIOCON is 2.45 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20242.45
Mar20232.06
Mar20221.31
Mar20211.36
Mar20201.29

How is Fixed Capital/Sales of BIOCON Trending?

Years Fixed Capital/Sales % Change
Mar2024 2.45
18.93
Mar2023 2.06
57.25
Mar2022 1.31
-3.68
Mar2021 1.36
5.43
Mar2020 1.29 -

Other Financial Ratios of BIOCON


Compare Fixed Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹36,642.3 Cr -11.7% -8.5% 19.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,394.0 Cr -6.7% 2.6% 5% Stock Analytics
DIVIS LABORATORIES ₹142,920.0 Cr -6.6% -3.7% 43.8% Stock Analytics
CIPLA ₹114,383.0 Cr -5.3% -2.9% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,817.0 Cr -3.8% 1.8% 25.8% Stock Analytics
DR REDDYS LABORATORIES ₹91,385.4 Cr -4.9% -3.3% -10.2% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-11.7%

-8.5%

19.1%

SENSEX

-3.6%

-0.7%

-0.5%


You may also like the below Video Courses